📰 Plan Financial News
Page 2 - Plan Financial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Plan Financial. Real-time updates on events, politics, business and more.
May 21, 2024
Franklin Resources Inc. lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 20,575,600 shares of the biopharmaceutical company’s stock after selling 610,308 shares during the quarter. Franklin Resources Inc. owned approximately […]
May 20, 2024
BNP Paribas Asset Management Holding S.A. lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 23.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,517,100 shares of the biopharmaceutical company’s stock after selling 751,606 shares during the period. BNP […]
May 19, 2024
Applied Finance Capital Management LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 11.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 457,366 shares of the biopharmaceutical company’s stock after acquiring an additional 47,593 shares during the quarter. Applied Finance Capital Management LLC’s holdings in Pfizer were worth $13,168,000 at […]
May 18, 2024
Atlantic Edge Private Wealth Management LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 27,331 shares of the biopharmaceutical company’s stock, valued at approximately $787,000. Several other hedge […]
May 18, 2024
First Heartland Consultants Inc. boosted its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 43.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 13,013 shares of the biopharmaceutical company’s stock after acquiring an additional 3,933 shares during the period. First […]
May 16, 2024
Baader Bank Aktiengesellschaft lifted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 27.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 77,765 shares of the biopharmaceutical company’s stock after purchasing an additional 16,852 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in […]
May 7, 2024
Pfizer Inc. (NYSE:PFE – Get Free Report)’s stock price traded up 0.8% during trading on Monday . The company traded as high as $28.26 and last traded at $28.02. 11,031,535 shares changed hands during trading, a decline of 74% from the average session volume of 42,765,719 shares. The stock had previously closed at $27.81. Analyst […]
May 1, 2024
Naviter Wealth LLC trimmed its position in Pfizer Inc. (NYSE:PFE – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,557 shares of the biopharmaceutical company’s stock after selling 3,036 shares during the period. Naviter Wealth LLC’s […]
April 30, 2024
Kestra Private Wealth Services LLC lifted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 3.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 290,204 shares of the biopharmaceutical company’s stock after buying an additional 8,322 shares during the quarter. […]
April 29, 2024
McAdam LLC trimmed its position in shares of Amplify BlackSwan Growth & Treasury Core ETF (NYSEARCA:SWAN – Free Report) by 2.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 113,902 shares of the company’s stock after selling 3,151 shares during the quarter. McAdam […]